Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options. Salarius’ product portfolio includes seclidemstat, a reversible LSD1 inhibitor, which is being studied as a potential treatment for pediatric cancers, sarcomas, and other cancers with limited treatment options, and SP-3164, an oral small molecule targeted protein degrader. Seclidemstat is currently in a Phase 1/2 clinical trial for relapsed/refractory Ewing sarcoma and select additional sarcomas that share a similar biology to Ewing sarcoma, also referred to as Ewing-related or FET-rearranged sarcomas. Seclidemstat has received Fast Track Designation, Orphan Drug Designation, and Rare Pediatric Disease Designation for Ewing sarcoma from the U.S. Food and Drug Administration. Salarius is also exploring seclidemstat’s potential in several cancers with high unmet medical need, with a second Phase 1/2 clinical study in hematologic cancers, initiated by MD Anderson Cancer Center. Salarius has received financial support from the National Pediatric Cancer Foundation to advance the Ewing sarcoma clinical program and was also a recipient of a Product Development Award from the Cancer Prevention and Research Institute of Texas (CPRIT). For more information, please visit salariuspharma.com or follow Salarius on Twitter and LinkedIn.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 2450 Holcombe Blvd, Houston,texas 77021,united States
- Phone
- 346-772-0346
- In****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.salariuspharma.com
- HQ
- Houston, Texas
Salarius Pharmaceuticals Questions
Salarius Pharmaceuticals's helpline number is 346-772-0346
Salarius Pharmaceuticals's website is http://www.salariuspharma.com
Salarius Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/salarius-pharmaceuticals
Salarius Pharmaceuticals has
13 employees.
View email and phone details for 13
employees at Salarius Pharmaceuticals.
Salarius Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Salarius Pharmaceuticals's top competitors are
Iterion Therapeutics,
Timberlyne Therapeutics,
Decoy,
Decoy Therapeutics Inc.,
Tune Therapeutics,
Normunity,
Regenxbio,
Tvardi Therapeutics,
Kardigan,
Phio Pharmaceuticals Corp..
Salarius Pharmaceuticals's support email address is Info@SalariusPharma.com
Salarius Pharmaceuticals's categories are Pharmaceutical Manufacturing
Salarius Pharmaceuticals's founding year is 2011
